Condition: Generalized Anxiety Disorder (GAD) · Chronic Insomnia · Sponsor: University of Sao Paulo
This is an open-label pilot clinical trial to evaluate the effects of transcranial alternating current stimulation (tACS) in adults diagnosed with generalized anxiety disorder (GAD) and chronic primary insomnia. The study will involve 30 participants who will receive 20 sessions of tACS over four weeks. The stimulation will be delivered at 15 mA and 77.5 Hz using the Nexalin device. The main goal is to assess improvements in anxiety and sleep quality. Results from this study will provide preliminary evidence for future randomized controlled trials.
This description comes directly from the study's public registry record.
Andre R Brunoni, Professor · +55 (11) 2661-8159 · andre.brunoni@hc.fm.usp.br
Kallene S Vidal, Professor · +55 (11) 2661-8159 · kallenesummer@gmail.com
Always discuss trial participation with your own doctor first.
| University of São Paulo | São Paulo, São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07429578